Please assess the completion status of the following clinical trial:

Trial Title: Nutrition and Pharmacological Algorithm for Oncology Patients Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with a diagnosis of head/neck, lung, pancreatic cancer, or metastatic cancer from any solid tumor~2. Planned, ongoing, or recently treated patient (within the past 30 days) with chemotherapy, immunotherapy, and/or intravenous targeted biologic therapy~3. No previous use of appetite stimulants~4. All patients must sign study specific informed consent prior to being included in the study~5. No contraindication to appetite stimulants~Exclusion Criteria:~1. Patient \<18 years old~2. Contraindication to appetite stimulants

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with fair to good appetite (Type: ACTIVE_COMPARATOR): The patients with fair-good appetite (score on CNAQ more than 24) will not receive any pharmacological agents and will receive nutrition intervention alone.~CNAQ = Council on Nutrition Appetite Questionnaire
- Patients with poor to fair appetite (Type: EXPERIMENTAL): The patients with poor-fair appetite (score on CNAQ less than 24) will be provided nutrition intervention by the Registered Dietitian and then put into one of three pharmacological groups.~CNAQ = Council on Nutrition Appetite Questionnaire

Based on this trial design, predict the completion outcome and termination type (if applicable).